XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities    
Net earnings $ 761,033 $ 501,345
Adjustments to reconcile net earnings to cash from operating activities:    
Depreciation and amortization 218,236 205,844
Share-based compensation expense 25,053 15,591
Gain on sale of businesses 0 5,213
Other, net (11,969) (7,731)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):    
Accounts receivable, net (222,521) 31,631
Inventories (225,522) (19,360)
Prepaid expenses and other assets (38,290) (24,198)
Accounts payable 199,877 (104,571)
Accrued compensation and employee benefits 32,284 (13,136)
Accrued expenses and other liabilities 42,084 131,279
Accrued and deferred taxes, net 8,321 (24,562)
Net cash provided by operating activities 788,586 686,919
Investing Activities    
Additions to property, plant and equipment (121,157) (123,564)
Acquisitions, net of cash acquired (171,287) (258,674)
Proceeds from sale of property, plant, and equipment 6,570 5,090
Proceeds from sale of businesses 0 15,400
Other (768) (1,250)
Net Cash Provided by (Used in) Investing Activities (286,642) (362,998)
Financing Activities    
Repurchase of common stock, including prepayment under an accelerated share repurchase program (21,637) (52,916)
Change in commercial paper and notes payable 0 5,811
Dividends paid to stockholders (214,805) (213,028)
Payments to settle employee tax obligations on exercise of share-based awards (34,838) (21,450)
Other (3,518) (1,753)
Net cash used in by financing activities (274,798) (283,336)
Effect of Exchange Rate on Cash and Cash Equivalents (1,077) (10,337)
Net (decrease) increase in cash and cash equivalents 226,069 30,248
Cash and cash equivalents at beginning of period 513,075 397,253
Cash and cash equivalents at end of period $ 739,144 $ 427,501